Navigation Links
New Pathways Studied to Repair Nerves
Date:11/6/2008

Two different approaches seek to interfere with mechanisms that inhibit cell regeneration

THURSDAY, Nov. 6 (HealthDay News) -- Nerve cells in the spinal cord and brain can't be repaired now if they are severed or damaged, but two ways to get them to grow again are being proposed by separate groups of researchers.

The basic idea of both approaches is to interfere with the built-in mechanisms that prevent nerve cell regeneration. One approach attacks it from the outside of nerve cells, the other from the inside.

Zhigang He, an associate professor of neurology at Children's Hospital Boston, a teaching affiliate of Harvard University, compared the two approaches to different ways of starting a stalled auto.

"Their idea is that something is blocking the highway," said He, lead author of one of the two papers in the Nov. 7 issue of Science. "Our mechanism deals with possible engine trouble."

Growth controls are built into the genes of nerve cells, He said. His group has identified two of the key genes that inhibit the major growth pathway in nerve cells. When those two genes are knocked out, cells that are damaged or severed can grow new axons, the pathways that carry messages from cell to cell.

A study in which mice whose optic nerves were damaged showed up to 50 percent of those cells engineered to lack the two growth-inhibiting genes survived, compared to 20 percent of the cells carrying those genes. Significant axon growth was seen in up to 10 percent of the mice lacking the genes.

Genetic engineering is not necessary to achieve that kind of nerve growth, He said. "In the future, we could have small-molecule drugs to activate these pathways," He said. "Other people have studied this pathway already, and there are quite a few possible targets."

He's group has started to work with some candidate compounds. "It's too early to say if these compounds would be effective," he
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Embryonic Pathways Induce Stem Cell Traits
2. Breast cancer subtypes originate from different biological pathways
3. Stem Cell Marker Controls Pair of Key Cancer Pathways
4. Georgetown researchers find stem cell marker controls 2 key cancer pathways
5. Different Neural Pathways at Work Going Under, Coming Out of Anesthesia
6. Post-partum suicide attempt risks studied
7. Fish oil and red yeast rice studied for lowering blood cholesterol
8. Effects of healing touch therapy being studied
9. No difference in sleep of OSA patients studied in a hospital vs. a hotel-based sleep center
10. Eltrombopag studied in Idiopathic Thrombocytopenic Purpura
11. New treatment option studied for bladder cancer

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Pathways Studied to Repair Nerves
New Pathways Studied to Repair Nerves
(Date:11/30/2009)..., NEW ORLEANS, Nov. 30 ... of the global corporation Sodexo will hold a rall...ies and Maintenance headquarters, 3800 Desire Park... policy and arbitrary disciplinary policies that t...r an ill family member. Sodexo employees who clean...
(Date:11/30/2009)... , LOS ANGELES, Nov. 30 /PRNewswi...ions, the Robert Wood Johnson Foundation Center fo...NM-RWJF Center), and impreMedia, shows a widesprea...out the importance of health care reform and indic.... For the first time, health care tops the list of...
(Date:11/30/2009)..., SCHAFFHAUSEN, Switzerland, Nov. 30 /PRNewswire-... ) today announced that its 2010 annual general me...arch 10, 2010 at 3:00 p.m. Central European time a...1, 8002 Zurich, Switzerland. Registered shareholde...e entitled to vote at the annual general meeting. ...
(Date:11/30/2009)..., GAINESVILLE, Fla., Nov. 30 The l...rks the availability of the first FDA-cleared, ful...n and analysis by a radiologist of suspicious brea...veiled at the Radiological Society of North Americ...in partnership with leading experts in breast MRI,...
(Date:11/30/2009)..., Ont., November 30, 2009 ― Providing free m...years to patients, lives at a relatively low cost ...dy by researchers at St. Michael,s Hospital in Tor...effective prescribed medications because they simp... Dhalla, the study,s lead author and a physician a...
Breaking Medicine News(10 mins):Health News:As H1NI Hits New Orleans in Force: School Custodians to Hold Rally to Call on Contractor to Stop Penalizing Workers Coping With Illness 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 2Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 3Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 4Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 5Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 6Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 7Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 8Health News:New Survey Shows Overwhelming Support Among Latinos for Health Care Reform That Includes Public Option 9Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 2Health News:New Breast MRI Technology Enables Enhanced Breast Cancer Detection 3Health News:Coverage of inexpensive drugs may increase length and quality of life after heart attack 2
...erials made from metals and organic compounds is c...rials science just 10 years after its discovery, w... inflammable gases such as hydrogen and methane. ...ent research network, following a major workshop ...
...ore likely to be diagnosed with advanced cancers, ..., Feb. 18 (HealthDay News) -- People who either ha...e likely to be diagnosed with advanced cancers tha...no health insurance, the new study clearly shows t...
...Diagnostic Ultrasound Systems on Display, SHENZHE... Mindray,Medical International Limited (NYSE: MR ...of medical devices in China with a rapidly growing...Mindray,s president of international sales and mar...
...Tanning Setting an Exceptional Way to Promote ...IANAPOLIS, Feb. 18 Evidence of the critical role,...bility to prevent major,forms of cancer continues ...:, http://www.prnewswire.com/mnr/ets/27541/ , N...
...Strategic Focus on Late-Stage and Marketed ...nsylvania and OXFORD, England, February 18 /PRNews... specialty pharmaceutical,company focused on oncol...rleukin-6 antibody to GlaxoSmithKline,(GSK) for a ...
... the cognitive health of people, but now scientist...ng these learning and memory problems. A new Nati...rodents finds that increased levels of a stress ho...m memory. Moreover, when levels of the adrenal glu...
Other Medicine News:Health News:Novel organic metal hybrids that will revolutionize materials science and chemical engineering 2Health News:Timely Cancer Diagnosis Linked to Insurance Status 2Health News:Timely Cancer Diagnosis Linked to Insurance Status 3Health News:Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting 2Health News:Mindray to Exhibit at 2008 European Congress of Radiology Annual Meeting 3Health News:Video: Studies: Exposure to Ultraviolet Rays Best Way to Overcome Widespread Vitamin D Deficiency 2Health News:EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties 2Health News:EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties 3Health News:Stress hormone impacts memory, learning in diabetic rodents 2
(Date:11/30/2009)... , CHARLESTON, S.C., Nov. 30 ...um, "SEBIO 2009", will be held at the Charleston P... SC, on December 3-4, 2009. Dr. Cheryl Liljestran...patent attorneys with Stipkala LLC, will attend. ...ce companies, investors, scientists, entrepreneurs...
(Date:11/30/2009)... , NEW YORK, Nov. 30 Repo...report is available in its catalogue: ,, Europ...lysis and Forecasts to 2015 ,, http://www.rep...nvestment-Opportunities-Analysis-and-Forecasts-to-...ent Opportunities, Analysis and Forecasts to 2015 ...
(Date:11/30/2009)... , COVINA, Calif., Nov. 30 St...mmercialization agreement with Academia Sinica, th...ietary methods and Intellectual Property (IP) rela...ells. This method and IP was pioneered by a team ...Academia Sinica. Professor Lin is currently the e...
Breaking Medicine Technology:Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 2Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 3Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 4Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 5Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 6Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 7Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 8Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 9Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 10Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 11Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 12Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 13Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 14Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 15Reportlinker Adds Europe Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2015 16StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 2StemCyte Licenses Promising IP for Stem Cell Therapy to Treat Stroke 3FDA approved leukemia drugs shows promise in ovarian cancer cells 10671 1FDA approved leukemia drugs shows promise in ovarian cancer cells 10671 2Teen Obesity Ups MS Risk in Women 61052 1Teen Obesity Ups MS Risk in Women 61052 2Teen Obesity Ups MS Risk in Women 61052 3Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 1Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 2Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 3Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 4Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 5Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 6Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 7Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 8Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 9Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 10Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 11Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 12Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 13Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 14Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 15Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 16Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 17Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 18Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 19Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 20Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 21Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 22Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 23Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 24Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 25Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 26Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 27Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 28Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 29Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 30Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 31Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 32Tyco International Reports Fourth Quarter Earnings From Continuing Operations Before Special Items of 240 61 Per Share and GAAP Earnings of 240 44 P 61047 33
VACUETTE Paediatric EDTA Tubes - Non-ridged (pull cap)
VACUETTE EDTA tubes - Non-ridged (pull cap)
Lectora Authoring Software 2006
Anal Canal EMG Sensor
Medicine Products: